Neoleukin Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLTX and other ETFs, options, and stocks.

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.

CEO

Jonathan G. Drachman

CEOJonathan G. Drachman

Employees

Employees91

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2003

Founded2003

Employees

Employees91

NLTX Key Statistics

Market cap

25.14M

Market cap25.14M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

62.05K

Average volume62.05K

High today

—

High today—

Low today

—

Low today—

Open price

$0.58

Open price$0.58

Volume

0.00

Volume0.00

52 Week high

$3.84

52 Week high$3.84

52 Week low

$0.375

52 Week low$0.375

NLTX Earnings

-$0.30

-$0.20

-$0.10

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 1, After Hours

ActualExpected Mar 1, After Hours

Neoleukin Therapeutics

Why Robinhood?

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Show more

NLTX Key Statistics

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.